Product Information
GLIMEPIRIDE 4 MG TABLET is a generic product labeled by Legacy Pharmaceutical Packaging, LLC, priced at $0.0524 per EA under NDC 68645057390. Its NADAC has been published 435 times since Feb 28, 2018.
The High Outlier badge above means this manufacturer's average price in the Glimepiride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
4 mg/1
Manufacturer
Legacy Pharmaceutical Packaging, LLCNDC
68645057390
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GLIMEPIRIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077091On Market Since
10/6/2005
Pharmacological Classes
Price Statistics
The NADAC for GLIMEPIRIDE 4 MG TABLET has been published 435 times since Feb 28, 2018, and over the history we have for it it has declined 43.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0524 per EA |
|---|---|
| All-time high | $0.0920 (Mar 14, 2018) |
| All-time low | $0.0274 (May 22, 2024) |
| 52-week high | $0.0524 |
| 52-week low | $0.0375 |
| Median price | $0.0496 |
| Average price | $0.0518 |
| Largest weekly change | +73.8% (Jun 19, 2024) |
| Weeks tracked | 435 |
| Tracking since | Feb 28, 2018 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 38% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GLIMEPIRIDE 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLIMEPIRIDE 4 MG TABLET, manufactured by Legacy Pharmaceutical Packaging, LLC, is $0.0524 per EA (NDC 68645057390), effective Jun 24, 2026.
How has the price of GLIMEPIRIDE 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLIMEPIRIDE 4 MG TABLET has declined 43.0%. It has been tracked across 435 weekly CMS publications since Feb 28, 2018.
What are the highest and lowest recorded NADAC prices for GLIMEPIRIDE 4 MG TABLET?
Since Feb 28, 2018, the NADAC for GLIMEPIRIDE 4 MG TABLET has ranged from a low of $0.0274 (May 22, 2024) to a high of $0.0920 (Mar 14, 2018), with a median of $0.0496 per EA.
Are there cheaper alternatives to GLIMEPIRIDE 4 MG TABLET?
Yes. 9 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, GLIMEPIRIDE 4 MG TABLET, is $0.0323 per EA — about 38% below GLIMEPIRIDE 4 MG TABLET.
Who manufactures GLIMEPIRIDE 4 MG TABLET?
GLIMEPIRIDE 4 MG TABLET (NDC 68645057390) is labeled by Legacy Pharmaceutical Packaging, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification